Literature DB >> 12695427

Current targets: where are we today?

M Pringle1.   

Abstract

Implementation of the National Service Framework (NSF) for coronary heart disease has particular workload implications for primary care. Studies conducted in general practices known to be representative of practices across the country suggest that, in order to meet current targets, the average general practitioner with a 2000 patient list would need to address 444 disease control measures in 210 patients. These relate primarily to smoking cessation and control of blood pressure, cholesterol, and blood sugar. Despite the enormous scale of cardiovascular disease, a considerable degree of recording and activity is going on within primary care in response to the NSF. However, some areas of cardiovascular care appear to need particular improvement. For example, with respect to lipid management, many high risk patients have not had their lipids measured, while many of those on lipid lowering drugs are not achieving current targets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695427      PMCID: PMC1876295          DOI: 10.1136/heart.89.suppl_2.ii10

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  3 in total

1.  General practice workload implications of the national service framework for coronary heart disease: cross sectional survey.

Authors:  J Hippisley-Cox; M Pringle
Journal:  BMJ       Date:  2001-08-04

2.  A comparison of research general practices and their patients with other practices--a cross-sectional survey in Trent.

Authors:  Vicky Hammersley; Julia Hippisley-Cox; Andrew Wilson; Mike Pringle
Journal:  Br J Gen Pract       Date:  2002-06       Impact factor: 5.386

Review 3.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.